[{"address1": "1375 West Fulton Street", "address2": "Suite 1300", "city": "Chicago", "state": "IL", "zip": "60607", "country": "United States", "phone": "844 445 5704", "website": "https://www.xerispharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 394, "companyOfficers": [{"maxAge": 1, "name": "Mr. John P. Shannon", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1065572, "exercisedValue": 0, "unexercisedValue": 341267}, {"maxAge": 1, "name": "Mr. Kevin  McCulloch", "age": 61, "title": "President & COO", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 777048, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven M. Pieper", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 747017, "exercisedValue": 30004, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth P. Hecht J.D.", "age": 60, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 767825, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul R. Edick J.D.", "age": 68, "title": "Senior Advisor", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 2597639, "exercisedValue": 0, "unexercisedValue": 1357712}, {"maxAge": 1, "name": "Ms. Allison  Wey", "title": "Senior Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Conner", "title": "SVP of Quality and Chief Compliance & Risk Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kendal  Korte", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anh  Nguyen M.B.A., M.D.", "age": 49, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.9, "open": 7.91, "dayLow": 7.66, "dayHigh": 7.99, "regularMarketPreviousClose": 7.9, "regularMarketOpen": 7.91, "regularMarketDayLow": 7.66, "regularMarketDayHigh": 7.99, "payoutRatio": 0.0, "beta": 0.86, "forwardPE": -35.590908, "volume": 1473442, "regularMarketVolume": 1473442, "averageVolume": 2518357, "averageVolume10days": 2179270, "averageDailyVolume10Day": 2179270, "bid": 7.71, "ask": 7.95, "bidSize": 19, "askSize": 19, "marketCap": 1264388352, "fiftyTwoWeekLow": 2.48, "fiftyTwoWeekHigh": 8.02, "priceToSalesTrailing12Months": 5.139268, "fiftyDayAverage": 5.8666, "twoHundredDayAverage": 4.5164, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1462329216, "profitMargins": -0.13006, "floatShares": 154233128, "sharesOutstanding": 161480000, "sharesShort": 13346477, "sharesShortPriorMonth": 19554170, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.08270001, "heldPercentInsiders": 0.04044, "heldPercentInstitutions": 0.56588, "shortRatio": 4.56, "shortPercentOfFloat": 0.086, "impliedSharesOutstanding": 161480000, "bookValue": -0.12, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -31999000, "trailingEps": -0.2, "forwardEps": -0.22, "enterpriseToRevenue": 5.944, "enterpriseToEbitda": 174.481, "52WeekChange": 2.023166, "SandP52WeekChange": 0.16844666, "quoteType": "EQUITY", "currentPrice": 7.83, "targetHighPrice": 11.0, "targetLowPrice": 6.0, "targetMeanPrice": 9.0, "targetMedianPrice": 9.5, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 59285000, "totalCashPerShare": 0.367, "ebitda": 8381000, "totalDebt": 257223008, "quickRatio": 1.18, "currentRatio": 1.95, "totalRevenue": 246024992, "revenuePerShare": 1.613, "returnOnAssets": -0.00698, "grossProfits": 202328000, "freeCashflow": -788250, "operatingCashflow": -16179000, "revenueGrowth": 0.488, "grossMargins": 0.82238996, "ebitdaMargins": 0.03407, "operatingMargins": 0.062649995, "financialCurrency": "USD", "symbol": "XERS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_105901792", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1756511249, "regularMarketTime": 1756497600, "shortName": "Xeris Biopharma Holdings, Inc.", "longName": "Xeris Biopharma Holdings, Inc.", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "postMarketChangePercent": -2.55428, "postMarketPrice": 7.63, "postMarketChange": -0.2, "regularMarketChange": -0.0700002, "regularMarketDayRange": "7.66 - 7.99", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2518357, "fiftyTwoWeekLowChange": 5.35, "fiftyTwoWeekLowChangePercent": 2.157258, "fiftyTwoWeekRange": "2.48 - 8.02", "fiftyTwoWeekHighChange": -0.19000053, "fiftyTwoWeekHighChangePercent": -0.023690838, "fiftyTwoWeekChangePercent": 202.31659, "earningsTimestamp": 1754539200, "earningsTimestampStart": 1762518600, "earningsTimestampEnd": 1762518600, "earningsCallTimestampStart": 1754569800, "earningsCallTimestampEnd": 1754569800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.2, "epsForward": -0.22, "epsCurrentYear": -0.01, "priceEpsCurrentYear": -783.0, "fiftyDayAverageChange": 1.9633999, "fiftyDayAverageChangePercent": 0.33467424, "twoHundredDayAverageChange": 3.3136, "twoHundredDayAverageChangePercent": 0.73368174, "priceToBook": -65.25, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Xeris Pharmaceuticals, Inc.", "nameChangeDate": "2025-08-29", "averageAnalystRating": "1.5 - Strong Buy", "regularMarketChangePercent": -0.886078, "regularMarketPrice": 7.83, "cryptoTradeable": false, "displayName": "Xeris Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-08-30"}]